专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2012075623A1 CONFIGURING MASTER DATA BASED UPON SCENARIOS 审中-公开
标题翻译：配置基于场景的主数据
公开(公告)号：WO2012075623A1
公开(公告)日：2012-06-14
申请号：PCT/CN2010/079529
申请日：2010-12-07
申请人： SAP AG , GE, Cunhui , WU, Wei , DING, Jiran , YU, Haiyang , DU, Jianfeng , ZENG, Ying
发明人： GE, Cunhui , WU, Wei , DING, Jiran , YU, Haiyang , DU, Jianfeng , ZENG, Ying
IPC分类号： G06F17/00
CPC分类号： G06F17/30292 , Y02D10/45
摘要： Various embodiments of systems and methods for configuring a master data based upon a scenario are described herein. A method includes rendering a list of predefined master data, receiving a user's selection of a master data from the list of predefined master data, displaying a list of scenarios defined for the selected master data, receiving a user's selection of a scenario from the list of scenarios, and configuring the master data based upon the user selected scenario. The configuration of master data based upon the scenario, selected or defined by the user, makes the system very flexible, efficient, and user friendly. Further, the modification/configuration of the master data as per the requirement of the application (scenario) saves time and energy of the user (developer) in developing the application.
摘要翻译：这里描述了用于基于场景配置主数据的系统和方法的各种实施例。一种方法包括呈现预定义的主数据的列表，从预定义的主数据的列表接收用户对主数据的选择，显示为所选主数据定义的场景的列表，从列表中接收用户对场景的选择场景，并根据用户选择的场景配置主数据。基于由用户选择或定义的场景的主数据的配置使得系统非常灵活，高效和用户友好。此外，根据应用需求（场景）的主数据的修改/配置可以节省用户（开发人员）开发应用程序的时间和精力。

2. 发明申请

WO2019118888A1 TREATMENT OF FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES 审中-公开
公开(公告)号：WO2019118888A1
公开(公告)日：2019-06-20
申请号：PCT/US2018/065773
申请日：2018-12-14
申请人： THE UNIVERSITY OF CHICAGO , GOU, Xuewen , ZHAO, Yingming , DU, Jianfeng
发明人： GOU, Xuewen , ZHAO, Yingming , DU, Jianfeng , WU, Xiaoyang , YUE, Jiping , BECKER, Lev
IPC分类号： C07K14/705 , C12N5/06 , C12N9/64
摘要： Provided herein are macrophages engineered for treating fibrosis and ameliorating the effects of fibrotic lesions in various organs and tissues. Certain embodiments are directed to genetically-engineered macrophages capable of treating fibrosis or reducing fibrotic lesions. In certain aspects macrophages can be genetically-engineered to (1) target extracelluar matrix (ECM) or components thereof, (2) enhance degradation of ECM, or (3) target ECM and enhance degradation of ECM. Further provided is a cellular therapy product comprising a genetically-engineered macrophage comprising at least one of a recombinant targeting protein and a recombinant catalytic enzyme. Further provided is a method of treating an individual for fibrosis comprising administering the cellular therapy product.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式